More than 30 mutations in the LAMC2 gene have been identified
in people with Junctional Epidermolysis Bullosa (JEB). The more severe form of
the disease — ‘Herlitz JEB’ — results from
mutations that severely disrupt the production of functional ‘laminin 332’.
Most of these mutations lead to a premature stop signal in the instructions for
making the gamma (g) subunit of laminin
332, which prevents the assembly of this protein. Without laminin 332, the
epidermis is weakly connected to the underlying layers of skin. Friction even
minor trauma (such as rubbing or scratching) can cause the skin layers to
separate, leading to the formation of blisters. Infants with Herlitz JEB
develop widespread blistering that causes life-threatening complications.
Other LAMC2 gene mutations cause
the milder form of JEB — ‘non-Herlitz
JEB’. Some of these mutations alter single protein building blocks (amino
acids) in the gamma (g) subunit of laminin
332. Others add or delete a small number of amino acids in the gamma (g) subunit or change the way the gene's
instructions are used to make the subunit. The genetic changes responsible for
non-Herlitz JEB usually lead to the production of a laminin 332 protein that
retains some of its function. Affected individuals experience blistering, but
it may be limited to the hands, feet, knees, and elbows and often improves
after the newborn period.
No comments:
Post a Comment